General Information of Drug (ID: DMENSL5)

Drug Name
Aminosalicylic Acid Drug Info
Synonyms
4-Aminosalicylic acid; 65-49-6; Aminosalicylic acid; P-AMINOSALICYLIC ACID; Rezipas; Aminopar; Pamisyl; Parasalindon; Ferrosan; Deapasil; Apacil; Parasal; Paser; Paramycin; Gabbropas; Parasalicil; Pasnodia; Osacyl; Aminox; Pasolac; Pasmed; Propasa; Pasalon; Entepas; Pasdium; Pasara; Pamacyl; Pasem; Pasa; 2-Hydroxy-4-aminobenzoic acid; PASK; APAS; Para-Pas; Sanipirol-4; Hellipidyl; Pascorbic; PAS-C; Benzoic acid, 4-amino-2-hydroxy-; PAS (acid); Aminosalicylic Acid Resin Complex; Aminosalicylate Sodium
Indication
Disease Entry ICD 11 Status REF
Crohn disease DD70 Approved [1]
Inflammatory bowel disease DD72 Approved [2]
Pulmonary and extrapulmonary tuberculosis 1B10.Z Approved [2]
Pulmonary tuberculosis 1B10.Z Approved [1]
Ulcerative colitis DD71 Approved [1]
Cross-matching ID
PubChem CID
4649
ChEBI ID
CHEBI:27565
CAS Number
CAS 65-49-6
TTD Drug ID
DMENSL5
VARIDT Drug ID
DR01160
INTEDE Drug ID
DR1748

Molecule(s) Related to This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Dihydrofolate reductase (DHFR) TTYZVDJ DYR_HUMAN Modulator [3]
Prostaglandin G/H synthase 1 (COX-1) TT8NGED PGH1_HUMAN Modulator [3]
Prostaglandin G/H synthase 2 (COX-2) TTVKILB PGH2_HUMAN Modulator [3]

Drug Transporter (DTP)
DTP Name DTP ID UniProt ID Highest Status REF
Sodium-coupled neutral amino acid transporter 3 (SLC38A3) DTKWJH3 S38A3_HUMAN Approved [4]

Drug-Metabolizing Enzyme (DME)
DME Name DME ID UniProt ID Highest Status REF
N-acetyltransferase 2 (NAT2) DER7TA0 ARY2_HUMAN Approved [5]

The Expression Level of Molecule(s) in Normal Tissue of Major ADME-Related Organs

Molecule Molecule Type Gene Name Liver Colon Kidney Small Intestine
Prostaglandin G/H synthase 1 (COX-1) DTT PTGS1 6.09 7.747 6.04 7.023
Sodium-coupled neutral amino acid transporter 3 (SLC38A3) DTP SNAT3 8.347 5.545 3.722 4.524
N-acetyltransferase 2 (NAT2) DME NAT2 8.344 7.451 3.154 8.135
Molecule Expression Atlas in Normal Tissue of Major ADME-related organs

The Expression Level of Molecule(s) between Disease Section and Healthy Individual Tissue

The Studied Disease Crohn disease
ICD Disease Classification DD70
Molecule Name Molecule Type Gene Name p-value Fold-Change Z-score
Prostaglandin G/H synthase 2 (COX-2) DTT PTGS2 2.03E-07 1.68 3.86
Prostaglandin G/H synthase 1 (COX-1) DTT PTGS1 4.06E-03 -0.9 -2.26
Sodium-coupled neutral amino acid transporter 3 (SLC38A3) DTP SNAT3 1.97E-01 -1.70E-01 -3.65E-01
N-acetyltransferase 2 (NAT2) DME NAT2 1.27E-04 -1.50E+00 -3.00E+00
Molecular Expression Atlas between Disease Section and Healthy Individual Tissue

References

1 Aminosalicylic acid FDA Label
2 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
3 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services.
4 Identification of amino acids imparting acceptor substrate selectivity to human arylamine acetyltransferases NAT1 and NAT2. Biochem J. 2000 May 15;348 Pt 1:159-66.
5 Importance of the evaluation of N-acetyltransferase enzyme activity prior to 5-aminosalicylic acid medication for ulcerative colitis. Inflamm Bowel Dis. 2016 Aug;22(8):1793-802.